This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Nov;43(11):e538.

doi: 10.1097/CCM.0000000000001240.

Mortality and Extensively Drug Resistance: Drugs or Methods? That Is the Question!

Alberto Corona¹

Affiliations

PMID: 26468731
DOI: 10.1097/CCM.0000000000001240

Comment

Mortality and Extensively Drug Resistance: Drugs or Methods? That Is the Question!

Alberto Corona. Crit Care Med. 2015 Nov.

. 2015 Nov;43(11):e538.

doi: 10.1097/CCM.0000000000001240.

Author

Alberto Corona¹

Affiliation

¹ Intensive Care Unit, Azienda Ospedaliera Luigi Sacco, University of Milano, Milano, Italy.

PMID: 26468731
DOI: 10.1097/CCM.0000000000001240

No abstract available

PubMed Disclaimer

Comment on

Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia: A Multicenter Prospective Observational Study.
Cheng A, Chuang YC, Sun HY, Sheng WH, Yang CJ, Liao CH, Hsueh PR, Yang JL, Shen NJ, Wang JT, Hung CC, Chen YC, Chang SC. Cheng A, et al. Crit Care Med. 2015 Jun;43(6):1194-204. doi: 10.1097/CCM.0000000000000933. Crit Care Med. 2015. PMID: 25793437

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Medical
- MedlinePlus Health Information